PDCD1 and cancer: Besides this activity on effector immune cells, PD-L1 also delivers an intrinsic anti-apoptotic intracellular signal in cancer cells, thus conferring resistance to T cell-mediated death without relying on the PD-1-dependent inhibition of T cells [23].